Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meditoxin vs Botox for Glabellar Lines
NCT01237977Phase 3Completed
- Sponsor
- Medytox Inc.
- Start
- Nov 2009
- Primary completion
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Meditoxin in glabellar lines, sponsored by Medytox Inc.. Started Nov 2009; status: completed.
02
Drugs
Meditoxin
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT01237977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237977.